相关实验视频
Updated: Jun 19, 2025
12:08
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
9.2K
通过双重DC和NK激活增强mRNA癌症疫苗的工程CaP-Pickering乳液
Sihua Wu1, Yan Zhou2, Naoki Asakawa3
1State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100081, PR China; Division of Molecular Science, Graduate School of Science and Technology, Gunma University, 1-5-1, Tenjin-cho, Kiryu 376-8515, Japan.
概括
一种新的酸纳米颗粒稳定乳液 (CaP-PME) 有效地为癌症疫苗提供mRNA. 这个系统增强了免疫细胞的激活,与传统方法相比,它表现出优异的抗瘤效果.
科学领域:
- 生物技术是生物技术.
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 脂质纳米粒子 (LNP) 系统可以改善mRNA的表达,但对于有效的癌症疫苗来说,需要仔细平衡免疫激活.
- 树突细胞 (DC) 激活对于癌症疫苗接种策略中的免疫识别和反应至关重要.
研究的目的:
- 开发一种新型的水-在-油-在-水 (w/o/w) 皮克林乳液 (CaP-PME) 用于增强癌症疫苗接种中的mRNA输送.
- 评估CaP-PME在激活免疫细胞和调解抗瘤反应方面的疗效.
主要方法:
- 用酸纳米颗粒 (CaP-PME) 稳定的一种 w/o/w 皮克林乳液的开发,用于mRNA封装.
- 在已建立的瘤模型 (E.G7和B16-OVA) 中评估mRNA输送,DC激活,免疫细胞反应 (CD8+T细胞,NK细胞) 和抗瘤疗效.
主要成果:
- 通过调节细胞内离子平衡,CaP-PME有效地将mRNA输送到细胞质中,诱导促炎反应并激活DCs.
- 与LNP相比,CaP-PME表现出优选的DC向,增强了它们的激活和淋巴结迁移.
- 该系统引发了强大的干扰素γ介导的CD8+T细胞反应,促进了NK细胞的增殖和激活,导致瘤透和微环境改善.
- 在使用CaP-PME的EG7和B16-OVA瘤模型中观察到优异的抗瘤效应.
结论:
- 在癌症疫苗接种中,CaP-PME作为一种强大的mRNA输送载体,提供了改善的免疫细胞激活和抗瘤功效.
- 独特的皮克林乳液系统为增强癌症免疫疗法的LNP提供了一个有希望的替代方案.
- 对CaP-PME的进一步调查可能会导致基于mRNA的先进癌症疫苗配方.
相关概念视频
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498